台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    67.5
  • 漲跌
    ▼0.2
  • 漲幅
    -0.30%
  • 成交量
    30
  • 產業
    上櫃 生技醫療類股▼0.76%
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-台灣企銀-民雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

台灣企銀-民雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/02/2300.001.452.2452.20-1.4182-0.77%
2022/06/0100.00813.4013.40-8146-5.46%
2022/04/27215.0000.0014.9521321.51%
2022/04/22315.6500.0015.6531212.46%
2022/04/18316.6500.0016.953923.25%
2021/07/1600.00116.0015.85-1397-0.25%
2021/07/0900.00416.2516.10-4408-0.98%
2021/07/0800.00516.2516.10-5415-1.20%
2021/05/2000.00116.5516.60-1550-0.18%
2021/05/19517.4100.0016.9555470.91%
2021/05/17618.8800.0019.6065061.19%
2021/05/1400.00217.6517.90-2459-0.44%
2021/05/13219.4500.0019.5524340.46%
2021/02/2600.00118.1518.15-1230-0.43%
2021/02/1900.00815.1616.00-8171-4.67%
2021/02/0400.00115.4515.20-1175-0.57%
2021/02/0200.00315.3015.35-3195-1.54%
2021/01/22115.1500.0014.9012010.50%
2021/01/21215.3000.0015.2022070.96%
2021/01/20315.6300.0015.8032101.42%
2021/01/04117.0500.0017.0513500.29%
2020/12/30217.1000.0017.2023510.57%
2020/12/03218.6000.0018.6023680.54%
2020/11/13219.6000.0019.5524130.48%
2020/10/2300.00119.3519.70-1548-0.18%
2020/10/2000.001019.8019.80-10546-1.83%
2020/09/1500.00219.1819.15-21,377-0.15%
2020/09/0900.00219.3519.40-21,564-0.13%
2020/08/2000.00519.8519.70-52,121-0.24%
2020/08/19122.0500.0021.8012,1280.05%
2020/08/14223.60222.9022.9002,3070.00%
2020/08/07323.9000.0024.2032,3070.13%
2020/07/2900.00225.0025.55-22,273-0.09%
2020/07/28123.8000.0023.4012,2650.04%
2020/07/27225.2000.0024.9022,2480.09%
2020/07/24128.2500.0027.0012,2360.04%
2020/07/17126.6000.0026.1512,0680.05%
2020/07/16129.0500.0029.0512,0180.05%
2020/07/15230.5000.0030.8021,9830.10%
2020/07/1400.00232.7029.60-21,907-0.10%
2020/07/1300.00231.1031.55-21,793-0.11%
2020/07/1000.00428.7028.70-41,666-0.24%
2020/06/29422.0300.0022.3041,4060.28%
2020/06/1100.00420.4921.00-41,077-0.37%
2020/06/0900.00117.9517.40-1958-0.10%
2020/06/08217.35218.0018.0009460.00%
2020/06/04117.1000.0017.0019550.10%
2020/05/28418.9800.0018.5049780.41%
2020/05/2000.00214.8514.85-2827-0.24%
2020/03/1800.0018.908.72-1639-0.16%
2020/03/11112.0000.0011.5015630.18%
2020/03/06113.7500.0014.7515020.20%
2020/03/04115.0000.0014.9514590.22%
2019/11/2100.0019.9210.10-194-1.06%
2019/11/11110.1000.0010.101861.15%
2019/11/0500.00210.0010.00-286-2.30%
2019/10/16210.1000.0010.1021371.46%
2019/05/2400.0029.809.80-2103-1.93%
2019/01/0300.00111.4011.10-158-1.72%
2018/11/16112.7500.0012.901861.16%
2018/11/1300.00113.3013.20-186-1.16%
2018/09/26116.8500.0016.8511170.85%
2018/09/1100.00117.3017.10-1119-0.84%
2018/09/10118.4500.0018.4511120.89%
2018/06/1400.00117.9017.85-1396-0.25%
2018/05/1600.00118.5518.55-1397-0.25%
2018/05/08118.3000.0018.4013930.25%
2018/04/1900.00120.3020.90-1358-0.28%
2018/04/18220.0000.0019.9023510.57%
2018/04/17120.40121.0020.5503420.00%
2018/04/16121.3500.0021.3513290.30%
2018/04/1300.00123.8023.70-1302-0.33%
2018/01/1600.00119.3019.30-1192-0.52%
2018/01/03118.7500.0018.7511810.55%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音